VivoSeq
Other

Colorectal

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Colorectal is an early-stage landscape with 0 programs across 1 company. The most active players are Novartis.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

73/100

Attrition Rate

21/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Completed8 · 57%
Terminated3 · 21%
Unknown status2 · 14%
Recruiting1 · 7%

Trial Activity

14 trials

Intrathecal Opioids for Colorectal Resection
Completed·MMayo Clinic·Phase 4·NCT04752033·80 enrolled
Stage IV Colorectal CA ALIMTA
Completed·MMayo Clinic·Phase 1/2·NCT00166465·200 enrolled
Hartmann Versus Resection and Primary Anastomosis
Completed·ZZagazig University·Preclinical·NCT07696117·714 enrolled
Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors
Terminated··Phase 2·NCT03693846·11 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)